These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21880923)

  • 1. Loss of Mecp2 in substantia nigra dopamine neurons compromises the nigrostriatal pathway.
    Gantz SC; Ford CP; Neve KA; Williams JT
    J Neurosci; 2011 Aug; 31(35):12629-37. PubMed ID: 21880923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired hippocampal Ca2+ homeostasis and concomitant K+ channel dysfunction in a mouse model of Rett syndrome during anoxia.
    Kron M; Müller M
    Neuroscience; 2010 Nov; 171(1):300-15. PubMed ID: 20732392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological and functional alterations in the substantia nigra pars compacta of the Mecp2-null mouse.
    Panayotis N; Pratte M; Borges-Correia A; Ghata A; Villard L; Roux JC
    Neurobiol Dis; 2011 Feb; 41(2):385-97. PubMed ID: 20951208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MeCP2-mediated alterations of striatal features accompany psychomotor deficits in a mouse model of Rett syndrome.
    Kao FC; Su SH; Carlson GC; Liao W
    Brain Struct Funct; 2015 Jan; 220(1):419-34. PubMed ID: 24218106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mouse juvenile or adult slice with preserved functional nigro-striatal dopaminergic neurons.
    Ammari R; Lopez C; Fiorentino H; Gonon F; Hammond C
    Neuroscience; 2009 Mar; 159(1):3-6. PubMed ID: 19032976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anatomical and electrophysiological changes in striatal TH interneurons after loss of the nigrostriatal dopaminergic pathway.
    Ünal B; Shah F; Kothari J; Tepper JM
    Brain Struct Funct; 2015 Jan; 220(1):331-49. PubMed ID: 24173616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual control of dopamine synthesis and release by presynaptic and postsynaptic dopamine D2 receptors.
    Anzalone A; Lizardi-Ortiz JE; Ramos M; De Mei C; Hopf FW; Iaccarino C; Halbout B; Jacobsen J; Kinoshita C; Welter M; Caron MG; Bonci A; Sulzer D; Borrelli E
    J Neurosci; 2012 Jun; 32(26):9023-34. PubMed ID: 22745501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression.
    Chang Q; Khare G; Dani V; Nelson S; Jaenisch R
    Neuron; 2006 Feb; 49(3):341-8. PubMed ID: 16446138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical and cell-autonomous role for MeCP2 in synaptic scaling up.
    Blackman MP; Djukic B; Nelson SB; Turrigiano GG
    J Neurosci; 2012 Sep; 32(39):13529-36. PubMed ID: 23015442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of MeCP2 function is associated with distinct gene expression changes in the striatum.
    Zhao YT; Goffin D; Johnson BS; Zhou Z
    Neurobiol Dis; 2013 Nov; 59():257-66. PubMed ID: 23948639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are dopamine receptor and transporter changes in Rett syndrome reflected in Mecp2-deficient mice?
    Wong DF; Blue ME; Brašić JR; Nandi A; Valentine H; Stansfield KH; Rousset O; Bibat G; Yablonski ME; Johnston MV; Gjedde A; Naidu S
    Exp Neurol; 2018 Sep; 307():74-81. PubMed ID: 29782864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-synuclein overexpression in mice alters synaptic communication in the corticostriatal pathway.
    Wu N; Joshi PR; Cepeda C; Masliah E; Levine MS
    J Neurosci Res; 2010 Jun; 88(8):1764-76. PubMed ID: 20029978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism.
    Kozina EA; Khakimova GR; Khaindrava VG; Kucheryanu VG; Vorobyeva NE; Krasnov AN; Georgieva SG; Kerkerian-Le Goff L; Ugrumov MV
    J Neurol Sci; 2014 May; 340(1-2):198-207. PubMed ID: 24768159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural development of methyl-CpG-binding protein 2 null embryonic stem cells: a system for studying Rett syndrome.
    Okabe Y; Kusaga A; Takahashi T; Mitsumasu C; Murai Y; Tanaka E; Higashi H; Matsuishi T; Kosai K
    Brain Res; 2010 Nov; 1360():17-27. PubMed ID: 20816763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number.
    Chao HT; Zoghbi HY; Rosenmund C
    Neuron; 2007 Oct; 56(1):58-65. PubMed ID: 17920015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of locus ceruleus neurons in a mouse model of Rett syndrome.
    Taneja P; Ogier M; Brooks-Harris G; Schmid DA; Katz DM; Nelson SB
    J Neurosci; 2009 Sep; 29(39):12187-95. PubMed ID: 19793977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced axonal diameter of peripheral nerve fibers in a mouse model of Rett syndrome.
    Bahey NG; Gadalla KKE; McGonigal R; Bailey MES; Edgar JM; Cobb SR
    Neuroscience; 2017 Sep; 358():261-268. PubMed ID: 28687309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MeCP2 in the rostral striatum maintains local dopamine content critical for psychomotor control.
    Su SH; Kao FC; Huang YB; Liao W
    J Neurosci; 2015 Apr; 35(15):6209-20. PubMed ID: 25878291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-dependent modulation of GABA(A)-ergic synaptic transmission by allopregnanolone in locus coeruleus neurons of Mecp2-null mice.
    Jin X; Zhong W; Jiang C
    Am J Physiol Cell Physiol; 2013 Dec; 305(11):C1151-60. PubMed ID: 24067915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective GABAergic neurotransmission in the nucleus tractus solitarius in Mecp2-null mice, a model of Rett syndrome.
    Chen CY; Di Lucente J; Lin YC; Lien CC; Rogawski MA; Maezawa I; Jin LW
    Neurobiol Dis; 2018 Jan; 109(Pt A):25-32. PubMed ID: 28927958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.